Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients

Peddy Vishweshwar; Jennifer A. McMahon; Matthew L. Peterson; Magali B. Hickey; Tanise R. Shattock; Michael J. Zaworotko

doi:10.1039/b501304f

Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients

Peddy Vishweshwar
, Jennifer A. McMahon
, Matthew L. Peterson
, Magali B. Hickey
, Tanise R. Shattock
, Michael J. Zaworotko

University of South Florida
TransForm Pharmaceutical, Inc.

Research output: Contribution to journal › Article › peer-review

Abstract

The carboxylic acid-primary amide supramolecular heterosynthon is exploited for the generation of pharmaceutical co-crystals that contain two active pharmaceutical ingredients that are polymorphic in their pure forms.

Original language	English
Pages (from-to)	4601-4603
Number of pages	3
Journal	Chemical Communications
Issue number	36
DOIs	https://doi.org/10.1039/b501304f
Publication status	Published - 28 Sept 2005
Externally published	Yes

Access to Document

10.1039/b501304f

Cite this

@article{6315c87356e44217bf6fed50e6afdb66,

title = "Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients",

abstract = "The carboxylic acid-primary amide supramolecular heterosynthon is exploited for the generation of pharmaceutical co-crystals that contain two active pharmaceutical ingredients that are polymorphic in their pure forms.",

author = "Peddy Vishweshwar and McMahon, \{Jennifer A.\} and Peterson, \{Matthew L.\} and Hickey, \{Magali B.\} and Shattock, \{Tanise R.\} and Zaworotko, \{Michael J.\}",

year = "2005",

month = sep,

day = "28",

doi = "10.1039/b501304f",

language = "English",

pages = "4601--4603",

journal = "Chemical Communications",

issn = "1359-7345",

number = "36",

}

TY - JOUR

T1 - Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients

AU - Vishweshwar, Peddy

AU - McMahon, Jennifer A.

AU - Peterson, Matthew L.

AU - Hickey, Magali B.

AU - Shattock, Tanise R.

AU - Zaworotko, Michael J.

PY - 2005/9/28

Y1 - 2005/9/28

N2 - The carboxylic acid-primary amide supramolecular heterosynthon is exploited for the generation of pharmaceutical co-crystals that contain two active pharmaceutical ingredients that are polymorphic in their pure forms.

AB - The carboxylic acid-primary amide supramolecular heterosynthon is exploited for the generation of pharmaceutical co-crystals that contain two active pharmaceutical ingredients that are polymorphic in their pure forms.

UR - https://www.scopus.com/pages/publications/26444620704

U2 - 10.1039/b501304f

DO - 10.1039/b501304f

M3 - Article

C2 - 16158128

AN - SCOPUS:26444620704

SN - 1359-7345

SP - 4601

EP - 4603

JO - Chemical Communications

JF - Chemical Communications

IS - 36

ER -

Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients

Abstract

Access to Document

Other files and links

Fingerprint

Cite this